As of 2014, the global pharmaceutical market was worth about $1 trillion US dollars in sales and is expected to increase by US$300 billion within next two years. The ten largest companies with annual sales over $20 billion controlled over one-third of this market. The biggest pharmaceutical companies by sales according to the 2015 edition of Financial Times Global 500 companies are Jonhson & Johnson, Pfizer, Novartis, Roche, and Merck.
The industry is poised for rapid market expansion and R&D growth - which is of particular importance to the pharmaceutical industry - in developing countries such as Brazil, China, and India that could foreshadow a significant market shift for the industry. Today, the pharmaceutical industry, as well as information and communications technology and automobiles, is considered to be a highly R&D intensive sector with an average of 13 percent of net sales dedicated to R&D. Of the world's top 2,500 companies that invested in R&D in 2014 - spending a €607.2 billion, or about 90% of the world's total - 316 were from the pharma & biotech sector. These companies' combined R&D spending accounted for 15 percent of the global R&D investment that year. Moreover, the pharma & biotech industry achieved an R&D spending increase that was 6.8 percent above the world average in 2014.
However significant R&D expenditures are relative to the global net sales of the industry, the R&D price tag is only half as much as pharma companies' expenditures on marketing and far exceeds spending on public information on health. This leads to a conflict of interest between the business goals of manufacturers and social needs to select drugs based on best information available. Pharmaceutical companies have a role to play across several aspects of public health promotion and education, particularly in relation to shifting demographics and deficits in public health care.
Today Starbucks is the largest coffeehouse company in the world, with 24,395 retail locations as of the first quarter of 2016, followed distantly by such coffee shop chains as Dunkin Donuts with about 10,000 restaurants, Tim Hortons with 4,300 outlets, and Costa Coffee with nearly 1,700 stores worldwide. Starbucks was founded in 1971 in Seattle, Washington, and incorporated on November 4, 1985 to become the publicly traded Starbucks Corporation. Based on the company's positive, sustained operating results, it is ranked among Forbes' top-500 world's biggest public companies. As of 2015, Starbucks' profit was $2.5 billion and it had a market...
The Forbes Global 2000 is an annual ranking of the world’s top 2000 public companies published by Forbes magazine since 2003. The companies are ranked according to four basic metrics: profit, sales, assets and market value.In total, the world's 2000 biggest public companies account for $162 trillion in assets, $35 trillion in revenues, $2 trillion in profits and $44 trillion in market value, according to the 2016 list.The world's largest company by market value is still Apple, however, the technology industry juggernaut from Cupertino is not the leader by the overall score.For the second time, China’s three biggest banks occupied the top...
See also: America's Fortune 500 Companies | World's Top Banks | Top 500 Companies in Africa Source: TOP 200 Banks In Africa, 2013
See also: America's Fortune 500 Companies | World's Top Banks | Top 200 Banks in Africa Source: Top 500 Companies In Africa, 2013